» Articles » PMID: 11162801

Epitopes on the Dengue 1 Virus Envelope Protein Recognized by Neutralizing IgM Monoclonal Antibodies

Overview
Journal Virology
Specialty Microbiology
Date 2001 Feb 13
PMID 11162801
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Three of 41 IgM monoclonal antibodies derived from dengue 1 virus immunized mice neutralized dengue 1 infection in vitro. All three neutralizing monoclonal antibodies reacted with spatially related epitopes on the E protein of dengue 1 which were also recognized by antibodies in sera from dengue patients. Two neutralization-resistant populations of dengue 1 virus, D1-M10 and D1-M17, were selected by sequential passage of virus in C6/36 cells in the presence of neutralizing IgM monoclonal antibodies M10 and M17, respectively. Single nucleotide changes occurred in the E protein gene of each of these virus populations resulting in single amino acid substitutions at E279 (Phe-Ser) in D1-M10 and at E293 (Thr-Ile) in D1-M17. Both neutralization-resistant populations of virus were more sensitive to elevated temperature than was the wild-type dengue 1 virus and the infectivity and haemagglutinating ability of the neutralization-resistant populations decreased more slowly than that of wild-type virus when exposed to pH in the range 5.8 to 7.0. These are the first epitopes involved in neutralization to have been identified in dengue 1 virus and the first outside domain III of the E protein on any dengue virus.

Citing Articles

Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism.

Liu H, Li Z, Reindl T, He Z, Qiu X, Golden R Nat Commun. 2024; 15(1):5179.

PMID: 38898037 PMC: 11187112. DOI: 10.1038/s41467-024-49161-9.


Identification of the flavivirus conserved residues in the envelope protein hinge region for the rational design of a candidate West Nile live-attenuated vaccine.

Maloney B, Carpio K, Bilyeu A, Saunders D, Park S, Pohl A NPJ Vaccines. 2023; 8(1):172.

PMID: 37932282 PMC: 10628263. DOI: 10.1038/s41541-023-00765-0.


Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.

Li P, Jang J, Hsia C, Groomes P, Lian W, de Wispelaere M ACS Infect Dis. 2019; 5(3):460-472.

PMID: 30608640 PMC: 6548335. DOI: 10.1021/acsinfecdis.8b00322.


A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis.

Goo L, VanBlargan L, Dowd K, Diamond M, Pierson T PLoS Pathog. 2017; 13(2):e1006178.

PMID: 28207910 PMC: 5312798. DOI: 10.1371/journal.ppat.1006178.


Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.

Ramanathan B, Poh C, Kirk K, McBride W, Aaskov J, Grollo L PLoS One. 2016; 11(5):e0155900.

PMID: 27223692 PMC: 4880327. DOI: 10.1371/journal.pone.0155900.